EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Early Remission of Cerebrospinal Fluid Interleukin‐6 After Initial Immunotherapy Predicts a Good Prognosis in Autoimmune Encephalitis

Yuta Madokoro, Yuto Uchida, Hiroyasu Inoue, Toyohiro Sato, Teppei Fujioka, Masayuki Mizuno, Shoji Kawashima, Masahiro Oomura, Noriyuki Matsukawa

Neurology and Clinical Neuroscience · 2026-11 · 14 (6) · 469-477

DOI: 10.1002/ncn3.70136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology and Clinical Neuroscience, online erschienen am 11.06.2026. Verfasst von Yuta Madokoro und 8 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autoimmune encephalitis therapy requires adjusting the regimen based on therapeutic response; however, clinical indicators of this response remain unknown.

Aim

To determine the predictive capability of cerebrospinal fluid (CSF), electroencephalography (EEG), and brain magnetic resonance imaging (MRI) in identifying responders to initial treatment for autoimmune encephalitis.

Methods

We retrospectively selected patients diagnosed with autoimmune encephalitis and treated at our hospital between April 1, 2015, and September 30, 2023. Patients were divided into initial first‐line treatment (FT) responders (those who did not require additional immunotherapy after the initial FT) and initial FT non‐responders (those who required two or more FT sessions or second‐line therapy). CSF, EEG, and brain MRI findings were analyzed before treatment initiation and at the first follow‐up examination. Duration of hospitalization and modified Rankin Scale (mRS) scores were compared between groups.

Results

Overall, 16 of the 27 selected patients with autoimmune encephalitis were classified as first FT responders, whereas 11 were non‐responders. CSF examination revealed a significantly lower interleukin‐6 (IL‐6) ratio (follow‐up IL‐6/pre‐FT IL‐6) in all responders (IL‐6 ratio < 1). No significant differences were observed between responders and non‐responders in background EEG rhythm frequency, the presence of epileptic discharges, or chronological MRI changes. The length of hospital stay and mRS scores at discharge were significantly lower in the initial FT responder group.

Conclusion

A lower CSF IL‐6 ratio may be a good predictive marker for response to initial therapy.

Zitieren

APA

Madokoro, Y., Uchida, Y., Inoue, H., Sato, T., Fujioka, T., Mizuno, M., Kawashima, S., Oomura, M., & Matsukawa, N. (2026). Early Remission of Cerebrospinal Fluid Interleukin‐6 After Initial Immunotherapy Predicts a Good Prognosis in Autoimmune Encephalitis. Neurology and Clinical Neuroscience, 14(6), 469-477. https://doi.org/10.1002/ncn3.70136

Vancouver

Madokoro Y, Uchida Y, Inoue H, Sato T, Fujioka T, Mizuno M, et al. Early Remission of Cerebrospinal Fluid Interleukin‐6 After Initial Immunotherapy Predicts a Good Prognosis in Autoimmune Encephalitis. Neurology and Clinical Neuroscience. 2026;14(6):469-477. doi:10.1002/ncn3.70136

BibTeX
@article{Madokoro2026,
  author = {Madokoro, Yuta and Uchida, Yuto and Inoue, Hiroyasu and Sato, Toyohiro and Fujioka, Teppei and Mizuno, Masayuki and Kawashima, Shoji and Oomura, Masahiro and Matsukawa, Noriyuki},
  title = {Early Remission of Cerebrospinal Fluid Interleukin‐6 After Initial Immunotherapy Predicts a Good Prognosis in Autoimmune Encephalitis},
  journal = {Neurology and Clinical Neuroscience},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {469--477},
  doi = {10.1002/ncn3.70136}
}
Kostenlos starten →